Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis-Reference-Cited by-同舟云学术

Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis

Published:2015-03-31 Issue:5 Volume:41 Page:1162-1170
ISSN:0586-7614
Container-title:Schizophrenia Bulletin
language:en
Short-container-title:SCHBUL

Author:

Mondelli Valeria,Ciufolini Simone,Belvederi Murri Martino,Bonaccorso Stefania,Di Forti Marta,Giordano Annalisa,Marques Tiago R.,Zunszain Patricia A.,Morgan Craig,Murray Robin M.,Pariante Carmine M.,Dazzan Paola

Publisher

Oxford University Press (OUP)

Subject

Psychiatry and Mental health

Link

http://academic.oup.com/schizophreniabulletin/article-pdf/41/5/1162/5415037/sbv028.pdf

Reference54 articles.

1. Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlates

2. Stress and the Hypothalamic Pituitary Adrenal Axis in the Developmental Course of Schizophrenia

3. The Stress Cascade and Schizophrenia: Etiology and Onset

4. Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline ‘Predictors’ and Longitudinal ‘Targets’

Cited by 229 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Childhood trauma types in relation to antipsychotic effectiveness in schizophrenia spectrum disorders: A prospective, pragmatic, randomized controlled study;Psychiatry Research;2024-11

2. Upregulated solute-carrier family genes in the hippocampus of schizophrenia can be rescued by antipsychotic medications;Schizophrenia Research;2024-10

3. Elevated plasma matrix metalloproteinase 9 in schizophrenia patients associated with poor antipsychotic treatment response and white matter density deficits;Schizophrenia;2024-08-27

4. Coping styles do not interact with the association between childhood trauma history and the immune-inflammatory phenotype of schizophrenia: Findings from a cross-sectional study;Psychoneuroendocrinology;2024-08

5. Assessment of Innovative Pharmacological Targets in Schizophrenia;Current Treatment Options in Psychiatry;2024-07-13